| P NOVN 12/22 | 6,65 / -5,00% |
| Fecha/Hora | 21.04. / 09:38 |
| Dif. / Dif.(%) | -0,35 / -5,00% |
| Bid | 6,35 / 0 |
| Ask | 6,85 / 0 |
| Apertura | 6,70 |
| Cierre del día anterior | 7,00 |
| Máxima sesión | 6,70 |
| Mínima sesión | 6,65 |
| Volumen [CHF] | 607,60 |
| Volumen [Unidades] | 91 |
| Fijación de precios | 10 |
| ISIN | DE000C3UM3D6 |
| Símbolo | NOVN |
| Bolsa | EUREX |
| Strike Price | 76.0000 |
| Tipo | Opción Put |
Noticias
- Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
22:15 - GlobeNewswire - Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
14:10 - GlobeNewswire - Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple Myeloma
14:00 - GlobeNewswire - TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial
14:00 - GlobeNewswire - Novartis to help Roche make potential COVID drug
15.04.2021 / 08:53 - TeleTrader
Tiempo real